Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Drugs - Real World Outcomes|January 13, 2021
The Xyrem® (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017Michael J Strunc, Jed Black, Prasheel Lillaney, et al.
Expert Opinion on Drug Discovery|November 24, 2021
Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomniaGunjan Junnarkar, Clark Allphin, Judi Profant, et al.
Nature and Science of Sleep|September 2, 2017
Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHADY Grace Wang, Khadra Benmedjahed, Jérémy Lambert, et al.
Sleep Medicine|April 29, 2014
The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findingsJed Black, Nancy L Reaven, Susan E Funk, et al.
Sleep|June 12, 2023
Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence studyRami H Ben-Joseph, Ragy Saad, Jed Black, et al.
Sleep Medicine|December 24, 2025
Effects of low-sodium oxybate on diary-based sleep time in a clinical study in adults with idiopathic hypersomniaAnne Marie Morse, Yves Dauvilliers, Logan D Schneider, et al.
Pageof 7